IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 59.92% | -41.95% | -70.31% | -84.28% | -87.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.86% | -41.96% | -70.30% | -84.27% | -87.92% |
| Cost of Revenue | -49.36% | -60.69% | -63.90% | -17.41% | -41.66% |
| Gross Profit | 75.94% | 71.80% | 57.50% | -261.63% | -756.93% |
| SG&A Expenses | -32.84% | -54.38% | -70.35% | -66.58% | -59.98% |
| Depreciation & Amortization | -79.00% | -83.41% | -81.20% | 12.22% | -44.94% |
| Other Operating Expenses | -34.24% | -30.24% | -28.56% | -9.40% | -17.42% |
| Total Operating Expenses | -42.81% | -49.65% | -55.08% | -37.61% | -38.07% |
| Operating Income | 44.51% | 49.89% | 54.49% | 34.75% | 33.52% |
| Income Before Tax | -2.38% | 25.65% | 32.72% | 30.60% | 64.64% |
| Income Tax Expenses | 100.00% | 61.99% | 64.75% | -1,066.47% | -1,469.17% |
| Earnings from Continuing Operations | -4.40% | 25.32% | 32.45% | 31.72% | 65.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.40% | 25.32% | 32.45% | 31.72% | 65.34% |
| EBIT | 44.51% | 49.89% | 54.49% | 34.75% | 33.52% |
| EBITDA | 39.47% | 43.86% | 50.51% | 39.83% | 37.87% |
| EPS Basic | 53.84% | 91.78% | 96.59% | 85.61% | 96.04% |
| Normalized Basic EPS | 84.57% | 95.03% | 98.18% | 78.87% | 91.71% |
| EPS Diluted | 53.61% | 91.70% | 96.58% | 85.78% | 96.18% |
| Normalized Diluted EPS | 84.58% | 95.03% | 98.18% | 78.86% | 91.69% |
| Average Basic Shares Outstanding | -75.52% | -79.50% | 7,002.46% | 8,160.66% | 8,157.37% |
| Average Diluted Shares Outstanding | -75.52% | -79.50% | 6,995.63% | 8,144.19% | 8,133.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |